Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 6:10:1092353.
doi: 10.3389/fpubh.2022.1092353. eCollection 2022.

Chronic liver diseases and erectile dysfunction

Affiliations
Review

Chronic liver diseases and erectile dysfunction

Guanghui Zang et al. Front Public Health. .

Abstract

Chronic liver diseases (CLDs) are characterized by progressive necrosis of hepatocytes, which leads to liver fibrosis and cirrhosis, and ultimately liver dysfunction. The statistics of 2020 shows that the number of patients with CLDs, including chronic hepatitis, fatty liver, and cirrhosis, may exceed 447 million in China. The liver is a crucial organ for the metabolism of various substances, including sex hormones and lipids. CLDs frequently result in abnormalities in the metabolism of sex hormones, glucose, and lipids, as well as mental and psychological illnesses, all of which are significant risk factors for erectile dysfunction (ED). It has been reported that the prevalence of ED in male patients with CLDs ranges from 24.6 to 85.0%. According to a survey of Caucasians, liver transplantation may improve the erectile function of CLDs patients with ED. This finding supports the link between CLDs and ED. In addition, ED is often a precursor to a variety of chronic diseases. Given this correlation and the significant prevalence of CLDs, it is important to evaluate the epidemiology, risk factors, etiology, and treatment outcomes of ED in male patients with CLDs, expecting to attract widespread attention.

Keywords: chronic hepatitis; chronic liver disease; erectile dysfunction; risk factors; testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mechanism by which IR leads to atherosclerosis and ED. IR can lead to vascular system demage and corpora cavernosa smooth muscle dysfunction through various mechanisms such as interference with signaling pathways, and ultimately lead to functional or organic ED.

Similar articles

Cited by

References

    1. Nguyen HMT, Gabrielson AT, Hellstrom WJG. Erectile dysfunction in young men-a review of the prevalence and risk factors. Sex Med Rev. (2017) 5:508–20. 10.1016/j.sxmr.2017.05.004 - DOI - PubMed
    1. Laumann EO, Glasser DB, Neves RC, Moreira ED, Group GI. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. (2009) 21:171–8. 10.1038/ijir.2009.7 - DOI - PubMed
    1. Wang W, Fan J, Huang G, Zhu X, Tian Y, Tan H, et al. . Meta-analysis of prevalence of erectile dysfunction in mainland China: evidence based on epidemiological surveys. Sex Med. (2017) 5:e19–30. 10.1016/j.esxm.2016.10.001 - DOI - PMC - PubMed
    1. Toda K, Miwa Y, Kuriyama S, Fukushima H, Shiraki M, Murakami N, et al. . Erectile dysfunction in patients with chronic viral liver disease: its relevance to protein malnutrition. J Gastroenterol. (2005) 40:894–900. 10.1007/s00535-005-1634-8 - DOI - PubMed
    1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. (2019) 70:151–71. 10.1016/j.jhep.2018.09.014 - DOI - PubMed

Publication types